Phase 2RecruitingNCT06455319
Precision ATG with or without verapamil in new-onset T1D
WAVE T1D phase 2 trial testing precision low-dose ATG followed by adalimumab or verapamil in newly diagnosed children and young adults.
Primary endpoints
- AUC C-peptide between ATG and placebo values
- Change in 2-hr MMTT AUC C-peptide
Results so far
No results posted yet.